physicians

Medical needle“/ CC0 1.0

On February 21, the FDA announced that the shortage of semaglutide injection products has been resolved. Semaglutide has appeared on the FDA’s Drug Shortage

Continue Reading End of Semaglutide Shortage Means Big Changes for Prescribers and Compounders

On January 5, 2023, the Federal Trade Commission (“FTC”) published a Notice of Proposed Rulemaking (“NPRM”) which would broadly prohibit companies from entering into or enforcing non-competition agreements or clauses

Continue Reading FTC Proposes Broad Rule Banning Non-Compete Covenants with Physicians and Other Healthcare Workers

The emergence of narrow network HMO products is a trend worth watching for several reasons: first, it demonstrates that third party payers are aggressively seeking to better manage health care costs and are looking for innovative ways to do so; and, second, it is apparent that as new products are developed, those providers who are integrated (both horizontally and vertically) are most likely to be the players of choice.
Continue Reading “Narrow Network” HMOs — An Emerging Trend Worth Watching